nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—SLC22A5—Niacin—atherosclerosis	0.289	0.556	CbGbCtD
Procainamide—CYP2D6—Niacin—atherosclerosis	0.0692	0.133	CbGbCtD
Procainamide—CYP2D6—Simvastatin—atherosclerosis	0.0547	0.105	CbGbCtD
Procainamide—CYP2D6—Lovastatin—atherosclerosis	0.0535	0.103	CbGbCtD
Procainamide—CYP2D6—Pravastatin—atherosclerosis	0.0535	0.103	CbGbCtD
Procainamide—Antinuclear antibody positive—Lovastatin—atherosclerosis	0.0155	0.0429	CcSEcCtD
Procainamide—Lupus-like syndrome—Lovastatin—atherosclerosis	0.0149	0.0413	CcSEcCtD
Procainamide—Lupus-like syndrome—Ezetimibe—atherosclerosis	0.0146	0.0405	CcSEcCtD
Procainamide—Antinuclear antibody positive—Simvastatin—atherosclerosis	0.0145	0.0401	CcSEcCtD
Procainamide—Lupus-like syndrome—Simvastatin—atherosclerosis	0.0139	0.0386	CcSEcCtD
Procainamide—Antinuclear antibody positive—Pravastatin—atherosclerosis	0.0131	0.0363	CcSEcCtD
Procainamide—Lupus erythematosus—Lovastatin—atherosclerosis	0.00942	0.0261	CcSEcCtD
Procainamide—Lupus erythematosus—Simvastatin—atherosclerosis	0.00881	0.0244	CcSEcCtD
Procainamide—Lupus erythematosus—Pravastatin—atherosclerosis	0.00797	0.0221	CcSEcCtD
Procainamide—Systemic lupus erythematosus—Lovastatin—atherosclerosis	0.00634	0.0176	CcSEcCtD
Procainamide—Systemic lupus erythematosus—Simvastatin—atherosclerosis	0.00593	0.0164	CcSEcCtD
Procainamide—DNMT1—Lovastatin—Simvastatin—atherosclerosis	0.00543	0.5	CbGdCrCtD
Procainamide—DNMT1—Lovastatin—Pravastatin—atherosclerosis	0.00543	0.5	CbGdCrCtD
Procainamide—Systemic lupus erythematosus—Pravastatin—atherosclerosis	0.00536	0.0149	CcSEcCtD
Procainamide—Hepatic enzyme increased—Rosuvastatin—atherosclerosis	0.00438	0.0121	CcSEcCtD
Procainamide—Hepatomegaly—Niacin—atherosclerosis	0.00426	0.0118	CcSEcCtD
Procainamide—Vasculitis—Lovastatin—atherosclerosis	0.0036	0.00997	CcSEcCtD
Procainamide—Vasculitis—Ezetimibe—atherosclerosis	0.00353	0.00978	CcSEcCtD
Procainamide—Vasculitis—Simvastatin—atherosclerosis	0.00336	0.00933	CcSEcCtD
Procainamide—Hepatic failure—Rosuvastatin—atherosclerosis	0.00334	0.00928	CcSEcCtD
Procainamide—Vasculitis—Pravastatin—atherosclerosis	0.00304	0.00843	CcSEcCtD
Procainamide—Hepatic failure—Lovastatin—atherosclerosis	0.00283	0.00786	CcSEcCtD
Procainamide—Haemolytic anaemia—Lovastatin—atherosclerosis	0.00282	0.00783	CcSEcCtD
Procainamide—Hepatic failure—Ezetimibe—atherosclerosis	0.00278	0.00771	CcSEcCtD
Procainamide—Rash maculo-papular—Niacin—atherosclerosis	0.00274	0.0076	CcSEcCtD
Procainamide—Hepatic failure—Simvastatin—atherosclerosis	0.00265	0.00735	CcSEcCtD
Procainamide—Haemolytic anaemia—Simvastatin—atherosclerosis	0.00264	0.00732	CcSEcCtD
Procainamide—Arthritis—Lovastatin—atherosclerosis	0.00262	0.00727	CcSEcCtD
Procainamide—Arthritis—Ezetimibe—atherosclerosis	0.00257	0.00713	CcSEcCtD
Procainamide—Atrial fibrillation—Simvastatin—atherosclerosis	0.00251	0.00697	CcSEcCtD
Procainamide—Arthritis—Simvastatin—atherosclerosis	0.00245	0.0068	CcSEcCtD
Procainamide—Hepatic failure—Pravastatin—atherosclerosis	0.0024	0.00665	CcSEcCtD
Procainamide—Haemolytic anaemia—Pravastatin—atherosclerosis	0.00239	0.00662	CcSEcCtD
Procainamide—Depression—Rosuvastatin—atherosclerosis	0.00231	0.00641	CcSEcCtD
Procainamide—Atrial fibrillation—Niacin—atherosclerosis	0.00231	0.0064	CcSEcCtD
Procainamide—Arthritis—Niacin—atherosclerosis	0.00225	0.00624	CcSEcCtD
Procainamide—Arthritis—Pravastatin—atherosclerosis	0.00222	0.00615	CcSEcCtD
Procainamide—Eosinophilia—Lovastatin—atherosclerosis	0.00218	0.00605	CcSEcCtD
Procainamide—Eosinophilia—Ezetimibe—atherosclerosis	0.00214	0.00593	CcSEcCtD
Procainamide—Abdominal discomfort—Lovastatin—atherosclerosis	0.00211	0.00585	CcSEcCtD
Procainamide—Eosinophilia—Simvastatin—atherosclerosis	0.00204	0.00566	CcSEcCtD
Procainamide—Abdominal discomfort—Simvastatin—atherosclerosis	0.00197	0.00548	CcSEcCtD
Procainamide—Eosinophilia—Pravastatin—atherosclerosis	0.00184	0.00511	CcSEcCtD
Procainamide—Depression—Simvastatin—atherosclerosis	0.00183	0.00508	CcSEcCtD
Procainamide—Sunitinib—CSF1R—atherosclerosis	0.00181	0.839	CrCbGaD
Procainamide—Depression—Pravastatin—atherosclerosis	0.00166	0.00459	CcSEcCtD
Procainamide—Angioedema—Rosuvastatin—atherosclerosis	0.00165	0.00459	CcSEcCtD
Procainamide—Flushing—Lovastatin—atherosclerosis	0.00164	0.00454	CcSEcCtD
Procainamide—Flushing—Ezetimibe—atherosclerosis	0.0016	0.00445	CcSEcCtD
Procainamide—Chills—Lovastatin—atherosclerosis	0.00158	0.00439	CcSEcCtD
Procainamide—Arthralgia—Rosuvastatin—atherosclerosis	0.00154	0.00427	CcSEcCtD
Procainamide—Myalgia—Rosuvastatin—atherosclerosis	0.00154	0.00427	CcSEcCtD
Procainamide—Flushing—Simvastatin—atherosclerosis	0.00153	0.00424	CcSEcCtD
Procainamide—Dysgeusia—Lovastatin—atherosclerosis	0.0015	0.00417	CcSEcCtD
Procainamide—Confusional state—Rosuvastatin—atherosclerosis	0.00149	0.00413	CcSEcCtD
Procainamide—Chills—Simvastatin—atherosclerosis	0.00148	0.0041	CcSEcCtD
Procainamide—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00145	0.00401	CcSEcCtD
Procainamide—Ill-defined disorder—Lovastatin—atherosclerosis	0.00142	0.00395	CcSEcCtD
Procainamide—Dysgeusia—Simvastatin—atherosclerosis	0.00141	0.0039	CcSEcCtD
Procainamide—Flushing—Niacin—atherosclerosis	0.0014	0.0039	CcSEcCtD
Procainamide—Angioedema—Lovastatin—atherosclerosis	0.0014	0.00389	CcSEcCtD
Procainamide—Ill-defined disorder—Ezetimibe—atherosclerosis	0.0014	0.00387	CcSEcCtD
Procainamide—Malaise—Lovastatin—atherosclerosis	0.00138	0.00384	CcSEcCtD
Procainamide—Cardiac disorder—Pravastatin—atherosclerosis	0.00138	0.00384	CcSEcCtD
Procainamide—Flushing—Pravastatin—atherosclerosis	0.00138	0.00384	CcSEcCtD
Procainamide—Angioedema—Ezetimibe—atherosclerosis	0.00137	0.00381	CcSEcCtD
Procainamide—Chills—Niacin—atherosclerosis	0.00136	0.00377	CcSEcCtD
Procainamide—Malaise—Ezetimibe—atherosclerosis	0.00136	0.00376	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00135	0.00373	CcSEcCtD
Procainamide—Chills—Pravastatin—atherosclerosis	0.00134	0.00371	CcSEcCtD
Procainamide—Ill-defined disorder—Simvastatin—atherosclerosis	0.00133	0.00369	CcSEcCtD
Procainamide—Angioedema—Simvastatin—atherosclerosis	0.00131	0.00364	CcSEcCtD
Procainamide—Arthralgia—Lovastatin—atherosclerosis	0.00131	0.00362	CcSEcCtD
Procainamide—Myalgia—Lovastatin—atherosclerosis	0.00131	0.00362	CcSEcCtD
Procainamide—Malaise—Simvastatin—atherosclerosis	0.00129	0.00359	CcSEcCtD
Procainamide—Discomfort—Lovastatin—atherosclerosis	0.00129	0.00358	CcSEcCtD
Procainamide—Myalgia—Ezetimibe—atherosclerosis	0.00128	0.00355	CcSEcCtD
Procainamide—Arthralgia—Ezetimibe—atherosclerosis	0.00128	0.00355	CcSEcCtD
Procainamide—Dysgeusia—Pravastatin—atherosclerosis	0.00127	0.00352	CcSEcCtD
Procainamide—Discomfort—Ezetimibe—atherosclerosis	0.00127	0.00351	CcSEcCtD
Procainamide—Confusional state—Lovastatin—atherosclerosis	0.00126	0.0035	CcSEcCtD
Procainamide—Confusional state—Ezetimibe—atherosclerosis	0.00124	0.00343	CcSEcCtD
Procainamide—Thrombocytopenia—Lovastatin—atherosclerosis	0.00123	0.0034	CcSEcCtD
Procainamide—Myalgia—Simvastatin—atherosclerosis	0.00122	0.00339	CcSEcCtD
Procainamide—Arthralgia—Simvastatin—atherosclerosis	0.00122	0.00339	CcSEcCtD
Procainamide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00122	0.00338	CcSEcCtD
Procainamide—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00121	0.00335	CcSEcCtD
Procainamide—Discomfort—Simvastatin—atherosclerosis	0.00121	0.00335	CcSEcCtD
Procainamide—Angioedema—Niacin—atherosclerosis	0.0012	0.00334	CcSEcCtD
Procainamide—Ill-defined disorder—Pravastatin—atherosclerosis	0.0012	0.00334	CcSEcCtD
Procainamide—Thrombocytopenia—Ezetimibe—atherosclerosis	0.0012	0.00333	CcSEcCtD
Procainamide—Anorexia—Lovastatin—atherosclerosis	0.00119	0.00331	CcSEcCtD
Procainamide—Angioedema—Pravastatin—atherosclerosis	0.00119	0.00329	CcSEcCtD
Procainamide—Confusional state—Simvastatin—atherosclerosis	0.00118	0.00328	CcSEcCtD
Procainamide—Urticaria—Rosuvastatin—atherosclerosis	0.00117	0.00326	CcSEcCtD
Procainamide—Malaise—Pravastatin—atherosclerosis	0.00117	0.00324	CcSEcCtD
Procainamide—Abdominal pain—Rosuvastatin—atherosclerosis	0.00117	0.00324	CcSEcCtD
Procainamide—Thrombocytopenia—Simvastatin—atherosclerosis	0.00115	0.00318	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00114	0.00316	CcSEcCtD
Procainamide—Myalgia—Niacin—atherosclerosis	0.00112	0.00311	CcSEcCtD
Procainamide—Arthralgia—Niacin—atherosclerosis	0.00112	0.00311	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00112	0.0031	CcSEcCtD
Procainamide—Anorexia—Simvastatin—atherosclerosis	0.00112	0.0031	CcSEcCtD
Procainamide—Myalgia—Pravastatin—atherosclerosis	0.0011	0.00306	CcSEcCtD
Procainamide—Arthralgia—Pravastatin—atherosclerosis	0.0011	0.00306	CcSEcCtD
Procainamide—Discomfort—Pravastatin—atherosclerosis	0.00109	0.00303	CcSEcCtD
Procainamide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00109	0.00302	CcSEcCtD
Procainamide—Decreased appetite—Lovastatin—atherosclerosis	0.00109	0.00302	CcSEcCtD
Procainamide—Confusional state—Pravastatin—atherosclerosis	0.00107	0.00296	CcSEcCtD
Procainamide—Decreased appetite—Ezetimibe—atherosclerosis	0.00107	0.00296	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00107	0.00296	CcSEcCtD
Procainamide—Asthenia—Rosuvastatin—atherosclerosis	0.00106	0.00294	CcSEcCtD
Procainamide—Shock—Niacin—atherosclerosis	0.00106	0.00293	CcSEcCtD
Procainamide—Pruritus—Rosuvastatin—atherosclerosis	0.00105	0.0029	CcSEcCtD
Procainamide—Thrombocytopenia—Pravastatin—atherosclerosis	0.00104	0.00288	CcSEcCtD
Procainamide—Feeling abnormal—Lovastatin—atherosclerosis	0.00103	0.00286	CcSEcCtD
Procainamide—Anorexia—Niacin—atherosclerosis	0.00102	0.00284	CcSEcCtD
Procainamide—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00102	0.00284	CcSEcCtD
Procainamide—Decreased appetite—Simvastatin—atherosclerosis	0.00102	0.00282	CcSEcCtD
Procainamide—Feeling abnormal—Ezetimibe—atherosclerosis	0.00101	0.00281	CcSEcCtD
Procainamide—Diarrhoea—Rosuvastatin—atherosclerosis	0.00101	0.0028	CcSEcCtD
Procainamide—Anorexia—Pravastatin—atherosclerosis	0.00101	0.0028	CcSEcCtD
Procainamide—Hypotension—Niacin—atherosclerosis	0.001	0.00279	CcSEcCtD
Procainamide—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.001	0.00279	CcSEcCtD
Procainamide—Urticaria—Lovastatin—atherosclerosis	0.000995	0.00276	CcSEcCtD
Procainamide—Body temperature increased—Lovastatin—atherosclerosis	0.00099	0.00275	CcSEcCtD
Procainamide—Abdominal pain—Lovastatin—atherosclerosis	0.00099	0.00275	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00098	0.00272	CcSEcCtD
Procainamide—Dizziness—Rosuvastatin—atherosclerosis	0.000977	0.00271	CcSEcCtD
Procainamide—Urticaria—Ezetimibe—atherosclerosis	0.000975	0.00271	CcSEcCtD
Procainamide—Abdominal pain—Ezetimibe—atherosclerosis	0.000971	0.00269	CcSEcCtD
Procainamide—Body temperature increased—Ezetimibe—atherosclerosis	0.000971	0.00269	CcSEcCtD
Procainamide—Feeling abnormal—Simvastatin—atherosclerosis	0.000965	0.00268	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000964	0.00268	CcSEcCtD
Procainamide—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000958	0.00266	CcSEcCtD
Procainamide—Decreased appetite—Niacin—atherosclerosis	0.000935	0.00259	CcSEcCtD
Procainamide—Urticaria—Simvastatin—atherosclerosis	0.00093	0.00258	CcSEcCtD
Procainamide—Body temperature increased—Simvastatin—atherosclerosis	0.000926	0.00257	CcSEcCtD
Procainamide—Abdominal pain—Simvastatin—atherosclerosis	0.000926	0.00257	CcSEcCtD
Procainamide—Hypersensitivity—Lovastatin—atherosclerosis	0.000922	0.00256	CcSEcCtD
Procainamide—Decreased appetite—Pravastatin—atherosclerosis	0.00092	0.00255	CcSEcCtD
Procainamide—Hypersensitivity—Ezetimibe—atherosclerosis	0.000905	0.00251	CcSEcCtD
Procainamide—Asthenia—Lovastatin—atherosclerosis	0.000898	0.00249	CcSEcCtD
Procainamide—Pruritus—Lovastatin—atherosclerosis	0.000886	0.00246	CcSEcCtD
Procainamide—Asthenia—Ezetimibe—atherosclerosis	0.000881	0.00244	CcSEcCtD
Procainamide—Gastrointestinal pain—Niacin—atherosclerosis	0.000879	0.00244	CcSEcCtD
Procainamide—Nausea—Rosuvastatin—atherosclerosis	0.000877	0.00243	CcSEcCtD
Procainamide—Feeling abnormal—Pravastatin—atherosclerosis	0.000872	0.00242	CcSEcCtD
Procainamide—Pruritus—Ezetimibe—atherosclerosis	0.000869	0.00241	CcSEcCtD
Procainamide—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000866	0.0024	CcSEcCtD
Procainamide—Hypersensitivity—Simvastatin—atherosclerosis	0.000863	0.00239	CcSEcCtD
Procainamide—Diarrhoea—Lovastatin—atherosclerosis	0.000857	0.00238	CcSEcCtD
Procainamide—Urticaria—Niacin—atherosclerosis	0.000854	0.00237	CcSEcCtD
Procainamide—Body temperature increased—Niacin—atherosclerosis	0.00085	0.00236	CcSEcCtD
Procainamide—Abdominal pain—Niacin—atherosclerosis	0.00085	0.00236	CcSEcCtD
Procainamide—Urticaria—Pravastatin—atherosclerosis	0.000841	0.00233	CcSEcCtD
Procainamide—Asthenia—Simvastatin—atherosclerosis	0.00084	0.00233	CcSEcCtD
Procainamide—Diarrhoea—Ezetimibe—atherosclerosis	0.00084	0.00233	CcSEcCtD
Procainamide—Abdominal pain—Pravastatin—atherosclerosis	0.000837	0.00232	CcSEcCtD
Procainamide—Body temperature increased—Pravastatin—atherosclerosis	0.000837	0.00232	CcSEcCtD
Procainamide—Pruritus—Simvastatin—atherosclerosis	0.000828	0.0023	CcSEcCtD
Procainamide—Dizziness—Lovastatin—atherosclerosis	0.000828	0.0023	CcSEcCtD
Procainamide—Dizziness—Ezetimibe—atherosclerosis	0.000812	0.00225	CcSEcCtD
Procainamide—Diarrhoea—Simvastatin—atherosclerosis	0.000801	0.00222	CcSEcCtD
Procainamide—Vomiting—Lovastatin—atherosclerosis	0.000796	0.00221	CcSEcCtD
Procainamide—Hypersensitivity—Niacin—atherosclerosis	0.000792	0.0022	CcSEcCtD
Procainamide—Vomiting—Ezetimibe—atherosclerosis	0.000781	0.00217	CcSEcCtD
Procainamide—Hypersensitivity—Pravastatin—atherosclerosis	0.00078	0.00216	CcSEcCtD
Procainamide—Dizziness—Simvastatin—atherosclerosis	0.000774	0.00215	CcSEcCtD
Procainamide—Asthenia—Niacin—atherosclerosis	0.000771	0.00214	CcSEcCtD
Procainamide—Pruritus—Niacin—atherosclerosis	0.000761	0.00211	CcSEcCtD
Procainamide—Asthenia—Pravastatin—atherosclerosis	0.00076	0.00211	CcSEcCtD
Procainamide—Pruritus—Pravastatin—atherosclerosis	0.000749	0.00208	CcSEcCtD
Procainamide—Vomiting—Simvastatin—atherosclerosis	0.000745	0.00207	CcSEcCtD
Procainamide—Nausea—Lovastatin—atherosclerosis	0.000744	0.00206	CcSEcCtD
Procainamide—Diarrhoea—Niacin—atherosclerosis	0.000736	0.00204	CcSEcCtD
Procainamide—Nausea—Ezetimibe—atherosclerosis	0.000729	0.00202	CcSEcCtD
Procainamide—Diarrhoea—Pravastatin—atherosclerosis	0.000724	0.00201	CcSEcCtD
Procainamide—Dizziness—Niacin—atherosclerosis	0.000711	0.00197	CcSEcCtD
Procainamide—Dizziness—Pravastatin—atherosclerosis	0.0007	0.00194	CcSEcCtD
Procainamide—Nausea—Simvastatin—atherosclerosis	0.000696	0.00193	CcSEcCtD
Procainamide—Vomiting—Niacin—atherosclerosis	0.000684	0.0019	CcSEcCtD
Procainamide—Vomiting—Pravastatin—atherosclerosis	0.000673	0.00187	CcSEcCtD
Procainamide—Nausea—Niacin—atherosclerosis	0.000639	0.00177	CcSEcCtD
Procainamide—Nausea—Pravastatin—atherosclerosis	0.000629	0.00174	CcSEcCtD
Procainamide—Probenecid—ALB—atherosclerosis	0.000346	0.161	CrCbGaD
Procainamide—CHRM2—Signaling Pathways—CCL4—atherosclerosis	3.23e-05	0.000304	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NAMPT—atherosclerosis	3.23e-05	0.000304	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.23e-05	0.000304	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—LIPC—atherosclerosis	3.21e-05	0.000302	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—MMP2—atherosclerosis	3.19e-05	0.000301	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOC3—atherosclerosis	3.19e-05	0.0003	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—KNG1—atherosclerosis	3.18e-05	0.0003	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GSTM1—atherosclerosis	3.18e-05	0.0003	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—LDLR—atherosclerosis	3.17e-05	0.000299	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.17e-05	0.000299	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AGTR1—atherosclerosis	3.16e-05	0.000298	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TNF—atherosclerosis	3.15e-05	0.000297	CbGpPWpGaD
Procainamide—BCHE—Metabolism—HMGCR—atherosclerosis	3.13e-05	0.000295	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ABCA1—atherosclerosis	3.13e-05	0.000295	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—LPL—atherosclerosis	3.12e-05	0.000294	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CETP—atherosclerosis	3.09e-05	0.000292	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—INS—atherosclerosis	3.04e-05	0.000287	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GPX1—atherosclerosis	3.04e-05	0.000287	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOA2—atherosclerosis	3.02e-05	0.000284	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NAMPT—atherosclerosis	3.01e-05	0.000284	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—CCL2—atherosclerosis	2.99e-05	0.000282	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—LIPC—atherosclerosis	2.99e-05	0.000282	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOC3—atherosclerosis	2.97e-05	0.00028	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CD36—atherosclerosis	2.96e-05	0.000279	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—SCARB1—atherosclerosis	2.96e-05	0.000279	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—LDLR—atherosclerosis	2.95e-05	0.000278	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—IGF1—atherosclerosis	2.94e-05	0.000278	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—KNG1—atherosclerosis	2.89e-05	0.000272	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CETP—atherosclerosis	2.88e-05	0.000272	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—UTS2—atherosclerosis	2.88e-05	0.000271	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AGTR1—atherosclerosis	2.87e-05	0.000271	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—MMP2—atherosclerosis	2.85e-05	0.000269	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.82e-05	0.000266	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—MTHFR—atherosclerosis	2.81e-05	0.000265	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—HMGCR—atherosclerosis	2.8e-05	0.000264	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ABCA1—atherosclerosis	2.79e-05	0.000263	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—SCARB1—atherosclerosis	2.76e-05	0.00026	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CX3CR1—atherosclerosis	2.76e-05	0.00026	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CASR—atherosclerosis	2.76e-05	0.00026	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PPARA—atherosclerosis	2.75e-05	0.00026	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ALB—atherosclerosis	2.74e-05	0.000259	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ABCG1—atherosclerosis	2.74e-05	0.000259	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CX3CL1—atherosclerosis	2.7e-05	0.000255	CbGpPWpGaD
Procainamide—ACHE—Metabolism—HMOX1—atherosclerosis	2.68e-05	0.000253	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—EDN1—atherosclerosis	2.68e-05	0.000253	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AGT—atherosclerosis	2.67e-05	0.000252	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CCL5—atherosclerosis	2.66e-05	0.000251	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—CXCL8—atherosclerosis	2.65e-05	0.00025	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—APOE—atherosclerosis	2.61e-05	0.000247	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—HMGCR—atherosclerosis	2.61e-05	0.000246	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CAV1—atherosclerosis	2.59e-05	0.000244	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—APOA1—atherosclerosis	2.58e-05	0.000244	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—FABP4—atherosclerosis	2.58e-05	0.000243	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LCAT—atherosclerosis	2.58e-05	0.000243	CbGpPWpGaD
Procainamide—ACHE—Metabolism—APOB—atherosclerosis	2.57e-05	0.000242	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CNR2—atherosclerosis	2.56e-05	0.000242	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CXCL8—atherosclerosis	2.56e-05	0.000242	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—MMP3—atherosclerosis	2.56e-05	0.000241	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ALB—atherosclerosis	2.56e-05	0.000241	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—IL6—atherosclerosis	2.54e-05	0.00024	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOA4—atherosclerosis	2.53e-05	0.000239	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PRKCG—atherosclerosis	2.53e-05	0.000238	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GSTM1—atherosclerosis	2.5e-05	0.000236	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ABCA1—atherosclerosis	2.49e-05	0.000235	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP7A1—atherosclerosis	2.48e-05	0.000234	CbGpPWpGaD
Procainamide—ACHE—Metabolism—LPL—atherosclerosis	2.45e-05	0.000232	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—EDN1—atherosclerosis	2.43e-05	0.000229	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCL5—atherosclerosis	2.41e-05	0.000228	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GPX1—atherosclerosis	2.4e-05	0.000226	CbGpPWpGaD
Procainamide—BCHE—Metabolism—HMOX1—atherosclerosis	2.39e-05	0.000226	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—CXCL8—atherosclerosis	2.37e-05	0.000223	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3CG—atherosclerosis	2.36e-05	0.000223	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—AKT1—atherosclerosis	2.35e-05	0.000221	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CD36—atherosclerosis	2.33e-05	0.00022	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ABCA1—atherosclerosis	2.32e-05	0.000219	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP27A1—atherosclerosis	2.3e-05	0.000217	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PRKCG—atherosclerosis	2.3e-05	0.000216	CbGpPWpGaD
Procainamide—BCHE—Metabolism—APOB—atherosclerosis	2.29e-05	0.000216	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VWF—atherosclerosis	2.29e-05	0.000216	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PPARG—atherosclerosis	2.28e-05	0.000215	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOC3—atherosclerosis	2.27e-05	0.000214	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LDLR—atherosclerosis	2.26e-05	0.000213	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—INS—atherosclerosis	2.23e-05	0.000211	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GSTM1—atherosclerosis	2.23e-05	0.00021	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AGT—atherosclerosis	2.22e-05	0.00021	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—AKT1—atherosclerosis	2.21e-05	0.000209	CbGpPWpGaD
Procainamide—ACHE—Metabolism—MTHFR—atherosclerosis	2.21e-05	0.000208	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL3—atherosclerosis	2.2e-05	0.000208	CbGpPWpGaD
Procainamide—BCHE—Metabolism—LPL—atherosclerosis	2.19e-05	0.000207	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOA2—atherosclerosis	2.18e-05	0.000205	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALOX15—atherosclerosis	2.18e-05	0.000205	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	2.18e-05	0.000205	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	2.18e-05	0.000205	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PPARA—atherosclerosis	2.17e-05	0.000205	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ABCG5—atherosclerosis	2.15e-05	0.000203	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—HMOX1—atherosclerosis	2.14e-05	0.000202	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GPX1—atherosclerosis	2.14e-05	0.000202	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NCF1—atherosclerosis	2.11e-05	0.000199	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AGT—atherosclerosis	2.1e-05	0.000198	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CD36—atherosclerosis	2.08e-05	0.000196	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LPA—atherosclerosis	2.08e-05	0.000196	CbGpPWpGaD
Procainamide—ACHE—Metabolism—APOE—atherosclerosis	2.06e-05	0.000194	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—F2—atherosclerosis	2.05e-05	0.000194	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOB—atherosclerosis	2.05e-05	0.000193	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ALB—atherosclerosis	2.05e-05	0.000193	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CAV1—atherosclerosis	2.04e-05	0.000192	CbGpPWpGaD
Procainamide—ACHE—Metabolism—APOA1—atherosclerosis	2.03e-05	0.000192	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AGT—atherosclerosis	2.02e-05	0.00019	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—BGN—atherosclerosis	2.01e-05	0.00019	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCR2—atherosclerosis	1.99e-05	0.000188	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EDNRA—atherosclerosis	1.99e-05	0.000188	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—HMOX1—atherosclerosis	1.99e-05	0.000188	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GSTM1—atherosclerosis	1.99e-05	0.000188	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOA5—atherosclerosis	1.99e-05	0.000188	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CYBA—atherosclerosis	1.99e-05	0.000187	CbGpPWpGaD
Procainamide—BCHE—Metabolism—MTHFR—atherosclerosis	1.97e-05	0.000186	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PIK3CG—atherosclerosis	1.97e-05	0.000185	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—NOS3—atherosclerosis	1.96e-05	0.000185	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—LPL—atherosclerosis	1.96e-05	0.000184	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PLAT—atherosclerosis	1.94e-05	0.000183	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GHRL—atherosclerosis	1.94e-05	0.000183	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PARP1—atherosclerosis	1.94e-05	0.000183	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PPARA—atherosclerosis	1.93e-05	0.000182	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.92e-05	0.000181	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOB—atherosclerosis	1.91e-05	0.00018	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GPX1—atherosclerosis	1.91e-05	0.00018	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AGT—atherosclerosis	1.87e-05	0.000177	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—F2—atherosclerosis	1.87e-05	0.000176	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CD36—atherosclerosis	1.86e-05	0.000175	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GSTM1—atherosclerosis	1.86e-05	0.000175	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3CG—atherosclerosis	1.86e-05	0.000175	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.85e-05	0.000175	CbGpPWpGaD
Procainamide—BCHE—Metabolism—APOE—atherosclerosis	1.84e-05	0.000173	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—LPL—atherosclerosis	1.82e-05	0.000172	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CAV1—atherosclerosis	1.82e-05	0.000172	CbGpPWpGaD
Procainamide—BCHE—Metabolism—APOA1—atherosclerosis	1.81e-05	0.000171	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PPARG—atherosclerosis	1.79e-05	0.000169	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTGS2—atherosclerosis	1.79e-05	0.000169	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	1.79e-05	0.000168	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GPX1—atherosclerosis	1.78e-05	0.000168	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MTHFR—atherosclerosis	1.76e-05	0.000166	CbGpPWpGaD
Procainamide—ACHE—Metabolism—INS—atherosclerosis	1.76e-05	0.000166	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CD36—atherosclerosis	1.73e-05	0.000163	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPARA—atherosclerosis	1.73e-05	0.000163	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KNG1—atherosclerosis	1.71e-05	0.000161	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	1.7e-05	0.00016	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AGT—atherosclerosis	1.67e-05	0.000158	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	1.66e-05	0.000157	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.66e-05	0.000157	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3CG—atherosclerosis	1.66e-05	0.000156	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PLG—atherosclerosis	1.65e-05	0.000156	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LIPC—atherosclerosis	1.65e-05	0.000156	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MTHFR—atherosclerosis	1.64e-05	0.000155	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOC3—atherosclerosis	1.64e-05	0.000155	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOE—atherosclerosis	1.64e-05	0.000155	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LDLR—atherosclerosis	1.63e-05	0.000154	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CAV1—atherosclerosis	1.62e-05	0.000153	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOA1—atherosclerosis	1.62e-05	0.000153	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ALB—atherosclerosis	1.61e-05	0.000152	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPARA—atherosclerosis	1.61e-05	0.000152	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PPARG—atherosclerosis	1.6e-05	0.000151	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CETP—atherosclerosis	1.59e-05	0.00015	CbGpPWpGaD
Procainamide—BCHE—Metabolism—INS—atherosclerosis	1.57e-05	0.000148	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	1.56e-05	0.000148	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AGT—atherosclerosis	1.56e-05	0.000147	CbGpPWpGaD
Procainamide—ACHE—Metabolism—NOS3—atherosclerosis	1.54e-05	0.000145	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOE—atherosclerosis	1.53e-05	0.000144	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.52e-05	0.000144	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CAV1—atherosclerosis	1.51e-05	0.000143	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MMP3—atherosclerosis	1.51e-05	0.000143	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOA1—atherosclerosis	1.51e-05	0.000142	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF2—atherosclerosis	1.5e-05	0.000142	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3CG—atherosclerosis	1.48e-05	0.00014	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOB—atherosclerosis	1.46e-05	0.000138	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	1.45e-05	0.000137	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.44e-05	0.000136	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ALB—atherosclerosis	1.44e-05	0.000136	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EDN1—atherosclerosis	1.44e-05	0.000136	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPARG—atherosclerosis	1.43e-05	0.000135	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL5—atherosclerosis	1.43e-05	0.000135	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTGS2—atherosclerosis	1.41e-05	0.000133	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—INS—atherosclerosis	1.4e-05	0.000132	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LPL—atherosclerosis	1.39e-05	0.000132	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3CG—atherosclerosis	1.38e-05	0.00013	CbGpPWpGaD
Procainamide—BCHE—Metabolism—NOS3—atherosclerosis	1.38e-05	0.00013	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	1.36e-05	0.000128	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPARG—atherosclerosis	1.33e-05	0.000126	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SPP1—atherosclerosis	1.32e-05	0.000125	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	1.31e-05	0.000124	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—INS—atherosclerosis	1.31e-05	0.000123	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ALB—atherosclerosis	1.28e-05	0.000121	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.28e-05	0.000121	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTGS2—atherosclerosis	1.26e-05	0.000119	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NOS3—atherosclerosis	1.23e-05	0.000116	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	1.22e-05	0.000115	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALB—atherosclerosis	1.2e-05	0.000113	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AGT—atherosclerosis	1.19e-05	0.000113	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOE—atherosclerosis	1.17e-05	0.00011	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LEP—atherosclerosis	1.17e-05	0.00011	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CAV1—atherosclerosis	1.16e-05	0.000109	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOA1—atherosclerosis	1.16e-05	0.000109	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NOS3—atherosclerosis	1.14e-05	0.000108	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTGS2—atherosclerosis	1.12e-05	0.000106	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ESR1—atherosclerosis	1.12e-05	0.000105	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—F2—atherosclerosis	1.1e-05	0.000104	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.1e-05	0.000104	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	1.05e-05	9.95e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOB—atherosclerosis	1.05e-05	9.95e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTGS2—atherosclerosis	1.05e-05	9.88e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.03e-05	9.68e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	1.01e-05	9.53e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LPL—atherosclerosis	1.01e-05	9.5e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—INS—atherosclerosis	9.99e-06	9.42e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL2—atherosclerosis	9.82e-06	9.27e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GPX1—atherosclerosis	9.82e-06	9.27e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF1—atherosclerosis	9.66e-06	9.11e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CD36—atherosclerosis	9.57e-06	9.02e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	9.17e-06	8.65e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MTHFR—atherosclerosis	9.07e-06	8.55e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AKT1—atherosclerosis	9e-06	8.49e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPARA—atherosclerosis	8.89e-06	8.39e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOS3—atherosclerosis	8.76e-06	8.26e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AGT—atherosclerosis	8.61e-06	8.13e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOE—atherosclerosis	8.44e-06	7.96e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CAV1—atherosclerosis	8.36e-06	7.89e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOA1—atherosclerosis	8.34e-06	7.87e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	7.77e-06	7.33e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3CG—atherosclerosis	7.62e-06	7.18e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	7.5e-06	7.08e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6—atherosclerosis	7.39e-06	6.97e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPARG—atherosclerosis	7.35e-06	6.93e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—INS—atherosclerosis	7.21e-06	6.8e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AKT1—atherosclerosis	7.09e-06	6.68e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MMP9—atherosclerosis	7.03e-06	6.63e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	6.95e-06	6.56e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	6.83e-06	6.44e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	6.81e-06	6.43e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALB—atherosclerosis	6.61e-06	6.24e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NOS3—atherosclerosis	6.32e-06	5.96e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AKT1—atherosclerosis	6.32e-06	5.96e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	6.31e-06	5.95e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—STAT3—atherosclerosis	6.25e-06	5.89e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	5.97e-06	5.63e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	5.79e-06	5.46e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTGS2—atherosclerosis	5.78e-06	5.45e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AKT1—atherosclerosis	5.65e-06	5.33e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AKT1—atherosclerosis	5.26e-06	4.96e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6—atherosclerosis	4.36e-06	4.12e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKT1—atherosclerosis	4.03e-06	3.8e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AKT1—atherosclerosis	2.91e-06	2.74e-05	CbGpPWpGaD
